ヨーネ病診断市場- 世界の産業規模、シェア、動向、機会、予測、セグメント、動物タイプ別、検査タイプ別、エンドユーザー別、地域別、競合、2020年～2030年

ヨーネ病診断の世界市場は、2024年に6億7,102万米ドルと評価され、予測期間には9億8,022万米ドルに達すると予測され、2030年までのCAGRは6.52%です。

世界ヨーネ病診断市場は、家畜集団におけるヨーネ病の有病率の増加により、早期診断と予防の重要性に対する認識が高まり、大きな成長を遂げています。ヨーネ病は、主にウシ、ヒツジ、ヤギが罹患する慢性の細菌感染症であり、農業セクターの主要な懸念事項として認識されています。動物の健康に対する関心の高まりと、未診断や診断の遅れに伴う経済的・生産的損失に対する意識の高まりが、診断ツールの需要を押し上げています。PCR（Polymerase Chain Reaction）やELISA（Enzyme-Linked Immunosorbent Assay）などの高度な診断技術の開発は、より正確でタイムリーな病気の検出を可能にし、市場の成長に大きく貢献しています。

ヨーネ病診断市場の主な促進要因には、食の安全や公衆衛生に直接影響を与える人獣共通感染症を管理するための政府の取り組みの増加が含まれます。さまざまな規制機関や保健機関が、ヨーネ病の蔓延を監視・抑制するためのプログラムを実施し、農家や獣医師の間で診断検査の利用を促進しています。さらに、遺伝子検査や分子診断などの先端技術の導入が進み、診断ソリューションの機能が拡大し、より利用しやすく効果的なものとなっています。無病の畜産物に対する需要の高まりは、食品安全基準に対する関心の高まりと相まって、ヨーネ病診断市場をさらに牽引しています。

このような機会にもかかわらず、ヨーネ病診断市場は将来の成長に影響を与えかねない課題に直面しています。主な障壁のひとつは、高度な診断技術のコストが高いことであり、特に発展途上地域の小規模農家にとっては法外なコストとなりうる。このため、特定の市場では検査の普及が制限され、診断市場の成長を阻害しています。さらに、ヨーネ病は潜伏期間が長いため早期発見が難しく、介入の遅れにつながります。このことは、ヨーネ病の管理と蔓延防止にタイムリーな診断を頼りにしている獣医師や農家にとって課題となります。さらに、市場は新しい診断薬の承認に関する規制の壁にも直面しており、革新的なソリューションのイントロダクションが遅れる可能性があります。市場の発展に伴い、これらの課題に対処することは、ヨーネ病診断の可能性を世界的に最大化する上で極めて重要です。

市場促進要因

ヨーネ病の有病率の上昇

無病の畜産物に対する需要の高まり

診断法の技術的進歩

主な市場課題

ヨーネ病の長い潜伏期間

新しい診断薬に対する規制上の障壁

主要市場動向

ポイントオブケア診断の統合

血清学的検査の増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のヨーネ病診断市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 動物タイプ別（ウシ、ヤギ、ヒツジ）
  • 検査タイプ別（ELISA、PCR、AGID、その他）
  • エンドユーザー別（動物病院・クリニック、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米のヨーネ病診断市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 動物タイプ別
  • 検査タイプ別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州のヨーネ病診断市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 動物タイプ別
  • 検査タイプ別
  • エンドユーザー別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のヨーネ病診断市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 動物タイプ別
  • 検査タイプ別
  • エンドユーザー別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米のヨーネ病診断市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 動物タイプ別
  • 検査タイプ別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのヨーネ病診断市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 動物タイプ別
  • 検査タイプ別
  • エンドユーザー別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併および買収（該当する場合）
• 製品の発売（該当する場合）
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Zoetis Inc.
• Thermo Fisher Scientific, Inc.
• PBD Biotech Ltd
• IDEXX Laboratories, Inc.
• Innovative Diagnostics SAS
• VMRD Inc.
• BIOMERIEUX S.A.
• INDICAL BIOSCIENCE GmbH
• Tetracore, Inc.
• Surefarm Ltd

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Johne's Disease Diagnostics Market was valued at USD 671.02 Million in 2024 and is expected to reach USD 980.22 Million in the forecast period with a CAGR of 6.52% through 2030. The Global Johne's Disease Diagnostics Market is witnessing significant growth due to the increasing prevalence of Johne's disease in livestock populations, which has raised awareness about the importance of early diagnosis and prevention. Johne's disease, a chronic bacterial infection primarily affecting cattle, sheep, and goats, has been recognized as a major concern for the agricultural sector. The rising focus on animal health, coupled with the growing awareness of the economic and productivity losses associated with undiagnosed or late-diagnosed cases, is driving the demand for diagnostic tools. The development of advanced diagnostic techniques, such as PCR (Polymerase Chain Reaction) and ELISA (Enzyme-Linked Immunosorbent Assay), has contributed significantly to market growth, offering more accurate and timely detection of the disease.

Key drivers for the Johne's disease diagnostics market include increasing government initiatives to control zoonotic diseases, which directly impact food safety and public health. Various regulatory bodies and health organizations are implementing programs to monitor and reduce the spread of Johne's disease, promoting the use of diagnostic testing among farmers and veterinarians. Moreover, the rising adoption of advanced technologies, such as genetic testing and molecular diagnostics, is expanding the capabilities of diagnostic solutions, making them more accessible and effective. The growing demand for disease-free livestock products, coupled with heightened attention on food safety standards, is further driving the market for Johne's disease diagnostics, as farmers and animal health professionals look to ensure the health of their herds.

Despite these opportunities, Johne's disease diagnostics market faces challenges that could affect its future growth. One of the main barriers is the high cost of advanced diagnostic technologies, which can be prohibitive for small-scale farmers, especially in developing regions. This limits the widespread adoption of testing in certain markets, impeding the growth of the diagnostic market. Additionally, the long incubation period of Johne's disease makes early detection difficult, leading to delayed interventions. This poses a challenge for veterinarians and farmers who rely on timely diagnoses to manage and prevent the spread of the disease. Furthermore, the market also faces regulatory barriers related to the approval of new diagnostic products, which could slow down the introduction of innovative solutions. As the market evolves, addressing these challenges will be crucial to maximizing the potential of Johne's disease diagnostics globally.

Key Market Drivers

Rising Prevalence of Johne's Disease

The rising prevalence of Johne's disease in livestock is one of the key drivers fueling the growth of the global Johne's Disease Diagnostics Market. Johne's disease, caused by Mycobacterium avium subspecies paratuberculosis (MAP), is an infectious and chronic disease that primarily affects cattle, sheep, goats, and other ruminants. It leads to severe gastrointestinal issues, weight loss, reduced milk production, and in some cases, death.

The increasing incidence of Johne's disease across livestock populations is pushing farmers and veterinarians to adopt more advanced diagnostic tools to detect the disease early and mitigate its impact on farm productivity. In the United States, a 2007 study by the National Animal Health Monitoring System (NAHMS) found that approximately 68% of U.S. dairy herds had at least one cow that tested positive for Johne's disease, with herd prevalence approaching 100% in larger dairy herds. The disease spreads through contaminated feed, water, and manure, making it difficult to control in large herds. As livestock operations grow in scale and density, the risk of disease transmission increases, further amplifying the need for effective diagnostic solutions.

Recent studies have shown that the prevalence of Johne's disease in small ruminants is also significant. A study conducted between May 2015 and June 2024 found that the apparent animal prevalence of Johne's disease was 1.0% in goats and 3.2% in sheep based on ELISA tests. PCR tests revealed a higher prevalence of 10.8% in goats and 2.3% in sheep. These findings emphasize the growing prevalence of the disease in various livestock populations and highlight the need for improved diagnostic tools to help detect the disease at an early stage, especially in small ruminants. Furthermore, in Europe, the herd-level prevalence of Johne's disease in dairy cattle is reported to be over 50%, with dairy herds being more commonly infected than beef cattle herds. This widespread prevalence, coupled with the economic impact of the disease on the livestock industry, makes early detection and control critical for mitigating losses.

As Johne's disease becomes more widespread, both the economic impact and the pressure on farmers to control the disease intensify. For farmers, the costs associated with the disease, including decreased milk yield, higher veterinary expenses, and culling of affected animals, are significant. This has made early detection and management of Johne's disease a priority. Diagnostic tools, such as PCR and ELISA tests, are being increasingly relied upon to identify infected animals before the disease spreads within herds. As the awareness of the disease's prevalence grows, there is a greater emphasis on implementing regular diagnostic testing to prevent large-scale outbreaks, driving demand for advanced diagnostic technologies in the market.

Growing Demand for Disease-Free Livestock Products

The growing demand for disease-free livestock products is a significant driver of the Global Johne's Disease Diagnostics Market. As consumers become increasingly concerned about the quality and safety of their food, there is heightened demand for animal products that are free from diseases like Johne's disease. Disease-free certification is now an essential criterion for accessing premium markets, particularly in regions where livestock diseases are a major concern. For example, countries in Europe and North America have stringent regulations for livestock health and disease-free certification, which drives farmers to implement regular diagnostic testing for diseases like Johne's.

In addition to consumer demand, international trade agreements and export regulations are placing greater emphasis on disease-free certification. Livestock products that can be traced back to herds with verified health statuses are more likely to meet export standards, opening up market opportunities for farmers in regions with strict biosecurity regulations. As a result, the adoption of Johne's disease diagnostic tools is gaining traction, as they are essential in confirming the health status of livestock.

The rise in awareness about the potential economic impact of Johne's disease also contributes to the increased demand for disease-free products. Johne's disease can lead to significant production losses, including reduced milk yield, poor growth rates, and increased veterinary costs. As such, livestock farmers are recognizing the importance of early detection and management of the disease to maintain herd productivity and prevent financial losses. These factors, combined with the demand for high-quality and disease-free animal products, are driving the growth of the Johne's disease diagnostics market, encouraging both large-scale and small-scale farmers to invest in testing solutions to ensure the health of their herds.

Technological Advancements in Diagnostic Methods

Technological advancements in diagnostic methods are one of the key drivers for the growth of the Global Johne's Disease Diagnostics Market. The introduction of more advanced and accurate diagnostic techniques has revolutionized the way Johne's disease is detected and managed. Traditional diagnostic methods such as fecal culture and microscopy were often time-consuming, labor-intensive, and less sensitive in detecting the disease, especially in its early stages. However, the development of molecular techniques, such as Polymerase Chain Reaction (PCR), has significantly improved the accuracy and speed of diagnosis. PCR allows for the detection of the genetic material of Mycobacterium avium subspecies paratuberculosis, the bacterium responsible for Johne's disease, at much lower concentrations than traditional methods, enabling earlier detection and more effective management.

In addition to PCR, the advancement of serological tests like Enzyme-Linked Immunosorbent Assay (ELISA) has further propelled the diagnostic capabilities in detecting Johne's disease. These tests are widely adopted due to their ease of use, cost-effectiveness, and the ability to conduct mass screenings for herds, which makes them suitable for large-scale agricultural applications. The continuous improvement of these diagnostic tools, including faster turnaround times, higher sensitivity, and reduced costs, has made Johne's disease testing more accessible to farmers worldwide.

The growing integration of artificial intelligence (AI) and machine learning in diagnostic devices is another significant advancement. These technologies can analyze complex data patterns from diagnostic tests, improving the accuracy of results and offering predictive insights into disease outbreaks. These technological advancements not only make testing more efficient but also enhance the ability to monitor and manage Johne's disease more effectively, driving the market for Johne's disease diagnostics.

Key Market Challenges

Long Incubation Period of Johne's Disease

One of the significant challenges in the Global Johne's Disease Diagnostics Market is the long incubation period of Johne's disease, which complicates the diagnosis and management of the disease. Johne's disease, caused by Mycobacterium avium subspecies paratuberculosis, has a slow incubation period, often ranging from 2 to 10 years before clinical signs become evident. This delayed onset of symptoms makes early detection particularly difficult, as infected animals can appear healthy for years, despite harboring the bacteria. By the time symptoms such as weight loss, diarrhea, and reduced milk production manifest, the disease may have already spread to other animals within the herd, resulting in higher transmission risks and more complex management.

The long incubation period reduces the effectiveness of diagnostic tests that rely on visible clinical signs to confirm infection. Infected animals may not test positive in early stages, further delaying identification. Traditional diagnostic methods like fecal culture or blood tests may not detect the disease until it reaches an advanced stage, when it becomes harder to manage. As a result, farmers may be unaware of the disease's presence in their herds, allowing it to spread undetected, leading to potential economic losses due to decreased productivity and herd health issues.

This long incubation period is particularly challenging for large-scale farms and dairy producers who require regular monitoring and preventive measures. The slow progression of the disease means that by the time a diagnosis is made, controlling the spread within herds becomes more difficult and costly. Thus, the lengthy incubation period not only hinders early diagnosis but also impedes effective disease control, making it a key challenge in the Johne's disease diagnostics market.

Regulatory Barriers to New Diagnostic Products

Regulatory barriers present a significant challenge to the Global Johne's Disease Diagnostics Market, hindering the timely approval and market entry of new diagnostic products. The regulatory environment for veterinary diagnostics, including Johne's disease, is complex and varies across different regions. In many countries, diagnostic products must undergo extensive testing and certification before they can be sold or used in the field. This rigorous process involves meeting strict standards for accuracy, reliability, and safety, which can delay the introduction of innovative solutions.

The process of obtaining regulatory approval is particularly challenging for new diagnostic technologies, as they often require large-scale clinical trials, data collection, and validation to demonstrate their effectiveness. For emerging diagnostic companies, this can be a lengthy and costly process, limiting their ability to bring products to market quickly. The high costs associated with regulatory compliance can also deter smaller companies from entering the market, reducing competition and innovation in the Johne's disease diagnostics space.

In addition to the general regulatory challenges, there is a lack of standardized procedures for the approval of diagnostic tools across different countries. Variations in regulatory frameworks make it difficult for diagnostic companies to navigate international markets and expand their product offerings. The discrepancies in regulatory requirements between countries can lead to delays in market entry and increase the cost of obtaining multiple approvals for the same product.

These regulatory barriers can stifle innovation and slow down the adoption of advanced diagnostic solutions for Johne's disease, which ultimately limits the growth of the market. Addressing these challenges through regulatory harmonization and streamlining approval processes is critical for accelerating the availability of new and improved diagnostic tools.

Key Market Trends

Integration of Point-of-Care Diagnostics

The integration of point-of-care (POC) diagnostics is a significant market trend in the Global Johne's Disease Diagnostics Market. POC diagnostic tools allow veterinary professionals and farmers to conduct tests onsite, without the need to send samples to a laboratory. This trend is driven by the growing need for quick and accurate disease detection, especially in remote areas where access to centralized diagnostic labs may be limited. POC diagnostics streamline the process of identifying Johne's disease in livestock, enabling faster results and more efficient decision-making. This immediacy is crucial for controlling the spread of the disease within herds, as early detection facilitates timely interventions to prevent further transmission.

These POC devices are typically portable, user-friendly, and capable of delivering reliable results in a short period. The convenience of having diagnostic tools readily available on the farm empowers veterinary professionals and farm owners to monitor herd health more effectively and reduce the need for costly travel and delays associated with laboratory testing. This is especially beneficial for large-scale operations, where timely diagnosis can significantly impact the herd's productivity and overall health.

As demand for real-time diagnostics increases, the market is seeing innovations in portable diagnostic devices designed specifically for Johne's disease. The adoption of these tools helps minimize the time lag between testing and treatment, enabling a proactive approach to disease management. The trend of integrating POC diagnostics is expected to accelerate as technology advances, with more affordable and accessible solutions becoming available, allowing farmers and veterinary professionals to implement preventive health measures efficiently and effectively.

Rising Use of Serological Testing

The rising use of serological testing is a significant trend in the Global Johne's Disease Diagnostics Market, driven by its cost-effectiveness, efficiency, and ease of implementation. Serological tests, particularly the Enzyme-Linked Immunosorbent Assay (ELISA), are widely used to detect antibodies or antigens related to Johne's disease in animals. These tests allow for the detection of infections even before clinical symptoms appear, enabling early diagnosis and more effective disease management. As Johne's disease can have a long incubation period with few visible signs in the early stages, the ability to identify infected animals through serological methods is a critical tool in controlling the spread of the disease within herds.

The growing preference for serological testing can be attributed to its simplicity and relatively low cost compared to more advanced diagnostic methods like PCR (Polymerase Chain Reaction). This makes it an attractive option for farmers, particularly those in developing regions where resources may be limited. The convenience of serological tests, which can be performed quickly and with minimal technical expertise, has led to their widespread adoption, especially in routine herd screening and monitoring programs.

As the livestock industry increasingly focuses on biosecurity and disease prevention, the demand for reliable and cost-effective diagnostic methods like serological testing is growing. Additionally, regulatory pressures and the need for disease-free certification for international trade have further fueled the adoption of these diagnostic tools. With greater awareness about Johne's disease and its impact on livestock health and productivity, serological testing is becoming an essential part of comprehensive herd health management plans. This trend is expected to continue as the livestock industry moves towards more preventive approaches to disease control.

Segmental Insights

Animal Type Insights

Based on the Animal Type, Cattle emerged as the dominant segment in the Global Johne's Disease Diagnostics Market in 2024. This is due to the significant impact of Johne's disease on the dairy and beef industries. Johne's disease, caused by Mycobacterium avium subspecies paratuberculosis, primarily affects cattle, leading to chronic diarrhea, weight loss, and decreased milk production, resulting in substantial economic losses for farmers. The dairy sector's growing emphasis on maintaining herd health and ensuring disease-free certification for market access is driving the demand for Johne's disease diagnostics in cattle. The implementation of early detection systems through diagnostic tests like PCR and serological tests (e.g., ELISA) helps manage the disease, reduce transmission, and improve herd productivity. In Pennsylvania, the Johne's disease Herd Certification Process provides a structured framework for veterinarians and herd owners to develop meaningful herd management plans, aiming to reduce infection rates and prevent the introduction of Johne's disease into herds. Cattle are also subjected to more stringent regulations regarding disease control, particularly in regions prioritizing the export of livestock or dairy products. In Montana, the Department of Livestock has developed a state Johne's Control Program to minimize the spread of Johne's disease through animal sales and movement, supporting non-infected herds by identifying biosecurity practices to prevent the introduction of the disease.

End User Insights

Based on the End User, Veterinary Hospitals & Clinics emerged as the dominant segment in the Global Johne's Disease Diagnostics Market in 2024. This dominance is due to their central role in diagnosing and managing animal diseases. Veterinary professionals are often the first point of contact for farmers and livestock owners seeking diagnostic solutions for Johne's disease. Veterinarians play an essential role in educating farmers about the disease, its risks, and the importance of early detection and management. With the increasing demand for disease-free certification in livestock and dairy products for both domestic markets and exports, veterinary hospitals and clinics are key in implementing monitoring and control programs for Johne's disease. These establishments are well-equipped to offer comprehensive diagnostic services, including regular screenings and the management of Johne's disease, which are essential for preventing its transmission. The rising awareness of Johne's disease and the growing focus on herd health management by farmers further boost the demand for veterinary diagnostic services. As Johne's disease poses significant economic risks, veterinary hospitals and clinics are increasingly relied upon to provide effective solutions for disease control and prevention.

Regional Insights

North America emerged as the dominant region in the Global Johne's Disease Diagnostics Market in 2024. This is primarily due to the region's strong emphasis on livestock health management, disease prevention, and regulatory standards. The United States, in particular, has a well-established veterinary infrastructure and regulatory frameworks that prioritize the control of Johne's disease in dairy and beef cattle. The U.S. Department of Agriculture (USDA) and state-level agencies have implemented several monitoring programs, including the Johne's Disease Herd Certification Program, which incentivizes dairy and cattle producers to engage in disease management and diagnostic testing. This regulatory environment drives the demand for Johne's disease diagnostics. In addition to regulatory requirements, the high economic stakes in the U.S. dairy and beef industries make early detection of Johne's disease critical. The disease can cause substantial financial losses due to decreased milk production, weight loss, and lower overall productivity in cattle. With growing awareness among farmers and veterinarians about the economic impact of the disease, there is an increased demand for diagnostic tools such as PCR and serological tests.

The strong market for veterinary diagnostic services, advanced testing technologies, and widespread government support for Johne's disease control measures have contributed to North America's dominance in the Global Johne's Disease Diagnostics Market.

Key Market Players

• Zoetis Inc.
• Thermo Fisher Scientific, Inc.
• PBD Biotech Ltd
• IDEXX Laboratories, Inc.
• Innovative Diagnostics SAS
• VMRD Inc.
• BIOMERIEUX S.A.
• INDICAL BIOSCIENCE GmbH
• Tetracore, Inc.
• Surefarm Ltd

Report Scope:

In this report, the Global Johne's Disease Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Johne's Disease Diagnostics Market, By Animal Type:

• Cattle
• Goat
• Sheep

Johne's Disease Diagnostics Market, By Test Type:

• ELISA
• PCR
• AGID
• Others

Johne's Disease Diagnostics Market, By End User:

• Veterinary Hospitals & Clinics
• Others

Johne's Disease Diagnostics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Johne's Disease Diagnostics Market.

Available Customizations:

Global Johne's Disease Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Johne's Disease Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Cattle, Goat, Sheep)
  • 5.2.2. By Test Type (ELISA, PCR, AGID, Others)
  • 5.2.3. By End User (Veterinary Hospitals & Clinics, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Johne's Disease Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Test Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Johne's Disease Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Test Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Johne's Disease Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Test Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Johne's Disease Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Test Type
      • 6.3.3.2.3. By End User

7. Europe Johne's Disease Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Test Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Johne's Disease Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Test Type
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Johne's Disease Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Test Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Johne's Disease Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Test Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Johne's Disease Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Test Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Johne's Disease Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Test Type
      • 7.3.5.2.3. By End User

8. Asia-Pacific Johne's Disease Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Test Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Johne's Disease Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Test Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Johne's Disease Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Test Type
      • 8.3.2.2.3. By End User
  • 8.3.3. South Korea Johne's Disease Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Test Type
      • 8.3.3.2.3. By End User
  • 8.3.4. Japan Johne's Disease Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal Type
      • 8.3.4.2.2. By Test Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Johne's Disease Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal Type
      • 8.3.5.2.2. By Test Type
      • 8.3.5.2.3. By End User

9. South America Johne's Disease Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Test Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Johne's Disease Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Test Type
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Johne's Disease Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Test Type
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Johne's Disease Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Test Type
      • 9.3.3.2.3. By End User

10. Middle East and Africa Johne's Disease Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type
  • 10.2.2. By Test Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Johne's Disease Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Test Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Johne's Disease Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Test Type
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Johne's Disease Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Test Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Zoetis Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Thermo Fisher Scientific, Inc.
• 14.3. PBD Biotech Ltd
• 14.4. IDEXX Laboratories, Inc.
• 14.5. Innovative Diagnostics SAS
• 14.6. VMRD Inc.
• 14.7. BIOMERIEUX S.A.
• 14.8. INDICAL BIOSCIENCE GmbH
• 14.9. Tetracore, Inc.
• 14.10. Surefarm Ltd

15. Strategic Recommendations

16. About Us & Disclaimer